Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First‐Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG‐1201 Study)

समान संसाधन

• The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)
  द्वारा: Nakayama, Goro, और अन्य
  प्रकाशित: (2017)
• Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
  द्वारा: Hattori, Norifumi, और अन्य
  प्रकाशित: (2019)
• The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)
  द्वारा: Nakayama, Goro, और अन्य
  प्रकाशित: (2012)
• Efficacy of enteral nutrients containing β-hydroxy-β-methylbutyrate, glutamine, and arginine for the patients with anastomotic leakage after gastrectomy: study protocol of a multicenter phase II clinical trial
  द्वारा: Kanda, Mitsuro, और अन्य
  प्रकाशित: (2018)
• Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
  द्वारा: Kanda, Mitsuro, और अन्य
  प्रकाशित: (2019)